DOCSLIB.ORG

New Functions of Long Noncoding Rnas During EMT and Tumor Progression Chunlai Li

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
New Functions of Long Noncoding Rnas During EMT and Tumor Progression Chunlai Li Cancer Cancer Research Highlights Research New Functions of Long Noncoding RNAs during EMT and Tumor Progression Chunlai Li Epithelial-to-mesenchymal transition (EMT) is orches- dysregulated in colorectal carcinoma and correlates with trated by aberrant activation of EMT transcription factors poor survival and prognosis. They present a new functional and expression of downstream target genes resulting in mechanism illustrating how the SATB2-AS1–SATB2–Snail increased tumor initiation, metastatic potential, and thera- axis is involved in epigenetic modification that regulates peutic resistance. In this issue of Cancer Research,Wangand colorectal carcinoma progression. colleagues show that the long noncoding RNA SATB2-AS1 is See related article by Wang et al., p. 3542 The epithelial-to-mesenchymal transition (EMT) is a dynamic plasm, nucleus, or nucleolus. The distinct cellular localization of a process, in which epithelial cells acquire mesenchymal features. It lncRNA determines its molecular function: cytoplasmic lncRNAs is characterized by loss of intercellular contacts and cellular are responsible for posttranscriptional regulation including polarity, and acquisition of motility and invasive properties (1). mRNA stability and protein modification (6); nuclear lncRNAs EMT is crucial during embryonic development, wound healing, have functions at the transcriptional level such as histone mod- tissue regeneration, and organ fibrosis. In addition to the funda- ification, alternative splicing, or direct transcriptional regula- mental role EMT plays in development, it is also involved in tion (7). Accumulating evidence demonstrate that dysregulated several pathologic processes, including tumor initiation and expression of lncRNAs could serve as biomarkers or therapeutic progression, and resistance to cancer therapies (2). targets in different oncogenic settings. Recent studies indicate that EMT is mediated by a set of EMT-activating transcription certain lncRNAs control EMT by regulating upstream signaling factors (EMT-TF), which include three protein families: Snail pathways or by directly acting on EMT-TFs (4). (Snail/SNAI1 and Slug/SNAI2), basic helix-loop-helix (TWIST1, In this issue of Cancer Research, Wang and colleagues report the TWIST2, and TCF3), and zinc-finger E-box-binding homeo- discovery of a new lncRNA that suppresses colorectal carcinoma box (ZEB1 and ZEB2). Several signaling pathways such as the progression by inhibiting EMT (8). The expression of lncRNAs in TGFb/SMAD, WNT/b-catenin, NOTCH, and receptor tyrosine colorectal carcinoma tissues with or without metastasis was kinase signaling pathways have been implicated in the activation determined to identify lncRNAs that play a role in colorectal of EMT. These pathways induce the expression of various EMT-TFs carcinoma metastasis. A long noncoding antisense transcript upon exposure to ligands in the tumor microenvironment (1). SATB2-AS1 (AK056625) was found to be significantly down- Over the past decade, noncoding RNAs [miRNAs and long regulated in colorectal carcinoma tissues with metastasis. These noncoding RNAs (lncRNA)] have emerged as novel regulators of findings were confirmed by measuring SATB2-AS1 expression in the expression and function of EMT-TF in different pathologic colorectal carcinoma tissues and a panel of colorectal carcinoma conditions (3, 4). Compared with miRNAs, our current knowl- cell lines, as well as an unpaired colorectal carcinoma population edge of lncRNA remain limited. Advances in massive sequencing from The Cancer Genome Atlas. The decreased expression of technology and mega-analyses have led to tens of thousands of SATB2-AS1 was associated with advanced stage and poor overall lncRNAs being discovered and annotated, and nearly 20,000 survival; SATB2-AS1 expression could therefore serve as an inde- lncRNAs have been identified with potential functional rele- pendent prognostic factor in patients with colorectal carcinoma. vance (5). LncRNAs are involved in various important biological Gain- and loss-of-function studies revealed SATB2-AS1 functions processes such as cellular homeostasis, stem cell differentiation, as a tumor suppressor as it inhibited cell proliferation, migration, development, and disease. LncRNAs are localized in the cyto- and invasion in vitro, and suppressed tumorigenesis and meta- stasis in vivo. Mechanistically, SATB2-AS1 upregulated the expression of the tumor suppressor special AT-rich sequence-binding protein Department of Experimental Therapeutics, The University of Texas MD 2 (SATB2). SATB2 expression positively correlated with SATB2- Anderson Cancer Center, Houston, Texas. AS1 expression in colorectal carcinoma. SATB2 is a nuclear matrix Corresponding Author: Chunlai Li, University of Texas MD Anderson Cancer DNA-binding protein that specifically binds to genomic nuclear Center, 1901 East Road, South Campus Research Building 4 (4SCR4.1130), matrix attachment regions (MAR) and participates in chromatin Houston, TX 77054. Phone: 713-563-5629; Fax: 713-745-1710; E-mail: [email protected] remodeling and transcriptional regulation (9). The nuclear local- ization of both SATB2 and SATB2-AS1 suggested that SATB2-AS1 Cancer Res 2019;79:3536–8 could be involved in the epigenetic modification of SATB2 by doi: 10.1158/0008-5472.CAN-19-1205 recruiting chromatin remodeling complexes to the SATB2 pro- Ó2019 American Association for Cancer Research. moter. Indeed, the authors demonstrated that SATB2-AS1 3536 Cancer Res; 79(14) July 15, 2019 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2019 American Association for Cancer Research. LncRNAs in EMT and Cancer recruited histone acetyltransferase p300 to the SATB2 promoter models of mammary gland morphogenesis and cutaneous and increased H3K9ac and H3K27ac levels at the SATB2 promoter wound healing demonstrate that the impaired EMT-TFs promote region, which led to transcriptional activation of SATB2. EMT when PTEN polyubiquitination is inhibited (10). These ENCODE data analysis also showed high levels of the epigenetic findings highlight the contrasting roles of lncRNAs in EMT. modification marks, H3K4me3, H3K9ac, H3K27ac, and p300, Although the authors show that the SATB2-AS1–SATB2–Snail within the SATB2 promoter region. The physical association of axis is involved in the progression of colorectal carcinoma, some SATB2-AS1 and p300 was validated using immunoprecipitation important questions arise from this study. First, additional studies and RNA pulldown, and p300 occupancy on the SATB2 promoter are needed to connect EMT-inducing signals (such as TGFb, WNT, region was demonstrated using chromatin immunoprecipitation and NOTCH signaling) to SATB2-AS1 activation and to investi- (ChIP). The authors therefore propose that SATB2-AS1 can serve gate the potential regulation of SATB2-AS1 by these signaling as a scaffold to recruit p300 to the SATB2 promoter and regulate its pathways that are active in specific oncogenic contexts. Second, a transcriptional activity. Overexpression of SATB2-AS1 or inhibi- set of miRNAs have been identified that regulate EMT-TFs during tion of histone deacetylases (HDAC) using trichostatin A development and tissue homeostasis; in addition, miRNAs can increased SATB2 expression, whereas inhibition of histone acet- target lncRNAs and modulate their expression (3, 4). Thus, the ylation using the acetyltransferase inhibitor C646 abolished this cross-talk between miRNAs and lncRNAs in EMT needs to be effect. In addition, loss-of-function and histologic analyses vali- explored further. Third, a central mechanism of action of lncRNAs dated that the activation of SATB2 by SATB2-AS1 was mediated by is mediated through interaction with proteins to regulate protein p300. Inhibition of p300 or SATB2 restored colorectal carcinoma function and interaction networks or guide the localization growth, migration, and invasion. of ribonucleoprotein complexes to specific subcellular compart- SATB2 is mainly expressed by epithelial cells of the colon and ments (6, 7). Thus, besides p300, other proteins could be inter- rectum (9), and its lower expression is positively correlated with acting with SATB2-AS1 to promote colorectal carcinoma enrichment of metastasis signatures and EMT. Wang and collea- initiation and metastasis through alternative oncogenic signaling gues found that ectopic overexpression of both SATB2-AS1 and pathways. Similarly, other EMT-TFs or drivers could be involved SATB2 led to decreased mRNA and decreased protein levels of in SATB2-AS1–dependent EMT and colorectal carcinoma progres- Snail, a central regulator of EMT. Sequence analysis revealed that sion. Answering these questions could deepen our understanding three potential SATB2-binding regions with AT-rich sequences of the complex nature and diverse factors that contribute to the resided within the Snail promoter; the specificity of these binding aggressiveness of colorectal carcinoma. sites was verified by ChIP-qPCR analysis. The recruitment of In conclusion, this study reveals a new link between lncRNAs HDACs to target gene promoters is a typical characteristic of and EMT mediated by epigenetic modulation. It also provides MAR-binding proteins such as SATB2 (9), therefore the associa- new insights into the regulatory mechanism of lncRNAs and tion between HDACs and SATB2/Snail was determined. Immu- potential targeting sites in colorectal carcinoma progression. noprecipitation and ChIP analyses verified that HDAC1 inter- Accumulating evidence indicates that conventional therapies acted
Load more

Recommended publications
  • Cortical Foxp2 Supports Behavioral Flexibility and Developmental Dopamine D1 Receptor Expression
    bioRxiv preprint doi: https://doi.org/10.1101/624973; this version posted May 2, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Cortical Foxp2 supports behavioral flexibility and developmental dopamine D1 receptor expression Marissa Co, Stephanie L. Hickey, Ashwinikumar Kulkarni, Matthew Harper, Genevieve Konopka* Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA *Correspondence: [email protected] Contact information Genevieve Konopka, Ph.D. Department of Neuroscience, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., ND4.300, Dallas, TX 75390-9111 TEL: 214-648-5135, FAX: 214-648-1801, Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/624973; this version posted May 2, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract FoxP2 encodes a forkhead box transcription factor required for the development of neural circuits underlying language, vocalization, and motor-skill learning. Human genetic studies have associated FOXP2 variation with neurodevelopmental disorders (NDDs), and within the cortex, it is coexpressed and interacts with other NDD-associated transcription factors. Cortical Foxp2 is required in mice for proper social interactions, but its role in other NDD-relevant behaviors and molecular pathways is unknown.
    [Show full text]
  • SATB2 Induction of a Neural Crest Mesenchyme-Like Program Drives Melanoma Invasion and Drug Resistance
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2-2-2021 SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance Maurizio Fazio Charles K. Kaufman et al Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs RESEARCH ARTICLE SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance Maurizio Fazio1,2†, Ellen van Rooijen1,2†, Michelle Dang1,2, Glenn van de Hoek1, Julien Ablain1,2, Jeffrey K Mito1,3, Song Yang1, Andrew Thomas1, Jonathan Michael1, Tania Fabo1,2, Rodsy Modhurima1,2, Patrizia Pessina4, Charles K Kaufman5,6, Yi Zhou1,2, Richard M White7, Leonard I Zon1,2* 1Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States; 2Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, United States; 3Brigham and Women’s Hospital, Department of Pathology, Boston, United States; 4Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States; 5Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, United States; 6Department of Developmental Biology, Washington University in Saint Louis, St. Louis, United States; 7Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, United States Abstract Recent genomic and scRNA-seq analyses of melanoma demonstrated a lack of recurrent genetic drivers of metastasis, while identifying common transcriptional states correlating *For correspondence: with invasion or drug resistance.
    [Show full text]
  • Figure S1. Reverse Transcription‑Quantitative PCR Analysis of ETV5 Mrna Expression Levels in Parental and ETV5 Stable Transfectants
    Figure S1. Reverse transcription‑quantitative PCR analysis of ETV5 mRNA expression levels in parental and ETV5 stable transfectants. (A) Hec1a and Hec1a‑ETV5 EC cell lines; (B) Ishikawa and Ishikawa‑ETV5 EC cell lines. **P<0.005, unpaired Student's t‑test. EC, endometrial cancer; ETV5, ETS variant transcription factor 5. Figure S2. Survival analysis of sample clusters 1‑4. Kaplan Meier graphs for (A) recurrence‑free and (B) overall survival. Survival curves were constructed using the Kaplan‑Meier method, and differences between sample cluster curves were analyzed by log‑rank test. Figure S3. ROC analysis of hub genes. For each gene, ROC curve (left) and mRNA expression levels (right) in control (n=35) and tumor (n=545) samples from The Cancer Genome Atlas Uterine Corpus Endometrioid Cancer cohort are shown. mRNA levels are expressed as Log2(x+1), where ‘x’ is the RSEM normalized expression value. ROC, receiver operating characteristic. Table SI. Clinicopathological characteristics of the GSE17025 dataset. Characteristic n % Atrophic endometrium 12 (postmenopausal) (Control group) Tumor stage I 91 100 Histology Endometrioid adenocarcinoma 79 86.81 Papillary serous 12 13.19 Histological grade Grade 1 30 32.97 Grade 2 36 39.56 Grade 3 25 27.47 Myometrial invasiona Superficial (<50%) 67 74.44 Deep (>50%) 23 25.56 aMyometrial invasion information was available for 90 of 91 tumor samples. Table SII. Clinicopathological characteristics of The Cancer Genome Atlas Uterine Corpus Endometrioid Cancer dataset. Characteristic n % Solid tissue normal 16 Tumor samples Stagea I 226 68.278 II 19 5.740 III 70 21.148 IV 16 4.834 Histology Endometrioid 271 81.381 Mixed 10 3.003 Serous 52 15.616 Histological grade Grade 1 78 23.423 Grade 2 91 27.327 Grade 3 164 49.249 Molecular subtypeb POLE 17 7.328 MSI 65 28.017 CN Low 90 38.793 CN High 60 25.862 CN, copy number; MSI, microsatellite instability; POLE, DNA polymerase ε.
    [Show full text]
  • SATB2 Gene SATB Homeobox 2
    SATB2 gene SATB homeobox 2 Normal Function The SATB2 gene provides instructions for making a protein that helps control the development of certain body systems. The SATB2 protein attaches to special regions of DNA called matrix attachment regions (MARs). These regions help determine the structure of chromatin, which is the complex of DNA and proteins that packages DNA into chromosomes. The structure of chromatin is one way that gene expression is regulated during development. By organizing chromatin structure, the SATB2 protein coordinates the activity of multiple genes involved in the development of certain body systems. In particular, the SATB2 protein promotes the maturation of cells that build bones (osteoblasts) and directs development of structures in the head and face. The protein also plays roles in the maturation and function of different types of nerve cells (neurons) in the brain. Health Conditions Related to Genetic Changes SATB2-associated syndrome Mutations in the SATB2 gene have been found to cause SATB2-associated syndrome. Individuals with this condition have intellectual disability and severe speech problems. They may also have an opening in the roof of the mouth, dental abnormalities, or other abnormalities of the head and face (craniofacial anomalies). Some of these mutations are deletions of large pieces of DNA that remove several genes, including SATB2. Other mutations add, remove, or rearrange smaller pieces of DNA within the SATB2 gene. Still other mutations change single DNA building blocks (nucleotides) in the SATB2 gene. It is likely that these genetic changes reduce the amount of functional SATB2 protein. Reduction of SATB2 function is thought to impair normal development of the brain and craniofacial structures, leading to intellectual disability, delayed speech, craniofacial anomalies, and other features of SATB2-associated syndrome.
    [Show full text]
  • Genetic Factors in Nonsyndromic Orofacial Clefts
    Published online: 2021-02-12 THIEME Review Article 101 Genetic Factors in Nonsyndromic Orofacial Clefts Mahamad Irfanulla Khan1 Prashanth C.S.2 Narasimha Murthy Srinath3 1 Department of Orthodontics & Dentofacial Orthopedics, The Oxford Address for correspondence Mahamad Irfanulla Khan, BDS, MDS, Dental College, Bangalore, Karnataka, India Department of Orthodontics & Dentofacial Orthopedics, The Oxford 2 Department of Orthodontics & Dentofacial Orthopedics, DAPM R.V. Dental College, Bangalore, Karnataka 560068, India Dental College, Bangalore, Karnataka, India (e-mail: [email protected]). 3 Department of Oral & Maxillofacial Surgery, Krishnadevaraya College of Dental Sciences, Bangalore, Karnataka, India Global Med Genet 2020;7:101–108. Abstract Orofacial clefts (OFCs) are the most common congenital birth defects in humans and immediately recognized at birth. The etiology remains complex and poorly understood and seems to result from multiple genetic and environmental factors along with gene– environment interactions. It can be classified into syndromic (30%) and nonsyndromic (70%) clefts. Nonsyndromic OFCs include clefts without any additional physical or Keywords cognitive deficits. Recently, various genetic approaches, such as genome-wide associ- ► orofacial clefts ation studies (GWAS), candidate gene association studies, and linkage analysis, have ► nonsyndromic identified multiple genes involved in the etiology of OFCs. ► genetics This article provides an insight into the multiple genes involved in the etiology of OFCs. ► gene mutation Identification of specific genetic causes of clefts helps in a better understanding of the ► genome-wide molecular pathogenesis of OFC. In the near future, it helps to provide a more accurate association study diagnosis, genetic counseling, personalized medicine for better clinical care, and ► linkage analysis prevention of OFCs.
    [Show full text]
  • Identifying the Risky SNP of Osteoporosis with ID3-PEP Decision Tree Algorithm
    Hindawi Complexity Volume 2017, Article ID 9194801, 8 pages https://doi.org/10.1155/2017/9194801 Research Article Identifying the Risky SNP of Osteoporosis with ID3-PEP Decision Tree Algorithm Jincai Yang,1 Huichao Gu,1 Xingpeng Jiang,1 Qingyang Huang,2 Xiaohua Hu,1 and Xianjun Shen1 1 School of Computer Science, Central China Normal University, Wuhan 430079, China 2School of Life Science, Central China Normal University, Wuhan 430079, China Correspondence should be addressed to Jincai Yang; [email protected] Received 31 March 2017; Revised 26 May 2017; Accepted 8 June 2017; Published 7 August 2017 Academic Editor: Fang-Xiang Wu Copyright © 2017 Jincai Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In the past 20 years, much progress has been made on the genetic analysis of osteoporosis. A number of genes and SNPs associated with osteoporosis have been found through GWAS method. In this paper, we intend to identify the suspected risky SNPs of osteoporosis with computational methods based on the known osteoporosis GWAS-associated SNPs. The process includes two steps. Firstly, we decided whether the genes associated with the suspected risky SNPs are associated with osteoporosis by using random walk algorithm on the PPI network of osteoporosis GWAS-associated genes and the genes associated with the suspected risky SNPs. In order to solve the overfitting problem in ID3 decision tree algorithm, we then classified the SNPs with positive results based on their features of position and function through a simplified classification decision tree which was constructed by ID3 decision tree algorithm with PEP (Pessimistic-Error Pruning).
    [Show full text]
  • The Heterogeneity of Osteosarcoma: the Role Played by Cancer Stem Cells Kristina Schiavone, Delphine Garnier, Marie-Françoise Heymann, Dominique Heymann
    The heterogeneity of osteosarcoma: the role played by cancer stem cells Kristina Schiavone, Delphine Garnier, Marie-Françoise Heymann, Dominique Heymann To cite this version: Kristina Schiavone, Delphine Garnier, Marie-Françoise Heymann, Dominique Heymann. The hetero- geneity of osteosarcoma: the role played by cancer stem cells. Advances in Experimental Medicine and Biology, Kluwer, 2019, 1139, pp.187-200. 10.1007/978-3-030-14366-4_11. inserm-02319227 HAL Id: inserm-02319227 https://www.hal.inserm.fr/inserm-02319227 Submitted on 17 Oct 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. The heterogeneity of osteosarcoma: the role played by cancer stem cells Kristina Schiavone1, Delphine Garnier2, Marie-Francoise Heymann2, Dominique Heymann1,2,* 1 INSERM, European Associated Laboratory “Sarcoma Research Unit”, Department of Oncology and Metabolism, Medical School, University of Sheffield, United Kingdom. 2 INSERM, Institut de Cancérologie de l’Ouest, LabCT, U1232, CRCINA, Université de Nantes, Université d’Angers, 44805 cedex, Saint Herblain, France. *Corresponding author Prof. D. Heymann Institut de Cancérologie de l’Ouest, INSERM, LabCT, Blvd Jacques Monod, 44805 Saint-Herblain, France Tel.: +33 (0) 240 679 841; E-mail: dominique.heymann@univ-nantes Keywords: tumour heterogeneity; gene mutation drivers; cancer stem-like cells; circulating tumour cells; monitoring; clinical trials 1 Abstract Osteosarcoma is the most common bone sarcoma and is one of the cancer entities characterized by the highest level of heterogeneity in humans.
    [Show full text]
  • Identification of Shared and Unique Gene Families Associated with Oral
    International Journal of Oral Science (2017) 9, 104–109 OPEN www.nature.com/ijos ORIGINAL ARTICLE Identification of shared and unique gene families associated with oral clefts Noriko Funato and Masataka Nakamura Oral clefts, the most frequent congenital birth defects in humans, are multifactorial disorders caused by genetic and environmental factors. Epidemiological studies point to different etiologies underlying the oral cleft phenotypes, cleft lip (CL), CL and/or palate (CL/P) and cleft palate (CP). More than 350 genes have syndromic and/or nonsyndromic oral cleft associations in humans. Although genes related to genetic disorders associated with oral cleft phenotypes are known, a gap between detecting these associations and interpretation of their biological importance has remained. Here, using a gene ontology analysis approach, we grouped these candidate genes on the basis of different functional categories to gain insight into the genetic etiology of oral clefts. We identified different genetic profiles and found correlations between the functions of gene products and oral cleft phenotypes. Our results indicate inherent differences in the genetic etiologies that underlie oral cleft phenotypes and support epidemiological evidence that genes associated with CL/P are both developmentally and genetically different from CP only, incomplete CP, and submucous CP. The epidemiological differences among cleft phenotypes may reflect differences in the underlying genetic causes. Understanding the different causative etiologies of oral clefts is
    [Show full text]
  • MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma Through a Sox9-Mediated Positive Feedback Loop
    Author Manuscript Published OnlineFirst on March 31, 2020; DOI: 10.1158/0008-5472.CAN-19-1764 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. MAFB promotes cancer stemness and tumorigenesis in osteosarcoma through a Sox9-mediated positive feedback loop Yanyan Chen1,†, Bin Wang2, †, Mengxi Huang1, †, Tao Wang 2, †, Chao Hu 3,†, Qin Liu 2, Dong Han 4, Cheng Chen1, Junliang Zhang5, Zhiping Li4, Chao Liu 6, Wenbin Lei 7,Yue Chang1, Meijuan Wu1,Dan Xiang1, Yitian Chen1, Rui Wang1, Weiqian Huang5, Zengjie Lei1 ,* and Xiaoyuan Chu1, * 1 Department of Medical Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province, People’s Republic of China 2 Department of Gastroenterology, Daping Hospital, Third Military Medical University (Ar- my Medical University), Chongqing, People’s Republic of China 3 Department of Orthopedics, 904 Hospital of PLA, North Xingyuan Road, Beitang Dis- trict, Wuxi, Jiangsu, People’s Republic of China 4 Department of Medical Oncology, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, Jiangsu Province, People’s Republic of China 5 Department of Orthopedics, Affiliated Jinling Hospital, Medical School of Nanjing Univer- sity, Nanjing, Jiangsu Province, People’s Republic of China 6 Department of Medical Oncology, Jinling Hospital, Nanjing Clinical School of Nanjing Medical University, Nanjing, Jiangsu Province, People’s Republic of China 7Department of Orthopedics, Tianshui Cooperation of Chinese and Western Medicine Hospi- tal, Tianshui, Gansu Province, People’s Republic of China * To whom correspondence should be addressed. Xiaoyuan Chu, Tel: +86-25-80860131, Fax: +86-25-80860131, Email: [email protected]; Zengjie Lei, Email: leiz- [email protected] ; †The authors wish it to be known that, in their opinion, the first five authors should be regard- ed as joint First Authors.
    [Show full text]
  • Artin TARGETING ESTROGEN RECEPTOR AS a STRATEGY for PERSONALIZED MEDICINE in OVARIAN CANCER by Courtney Lynn Andersen A.A., Libe
    TARGETING ESTROGEN RECEPTOR AS A STRATEGY FOR PERSONALIZED MEDICINE IN OVARIAN CANCER by Courtney Lynn Andersen A.A., Liberal Arts & Sciences, Middlesex Community College, 2008 B.S., Biological Sciences, University of Massachusetts Lowell, 2011 Submitted to the Graduate Faculty of the School of Medicine in partial fulfillment of the requirements for the degree of PhD in Molecular Pharmacology University of Pittsburgh artin 2016 UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE This dissertation was presented by Courtney L. Andersen It was defended on February 16, 2016 and approved by Don DeFranco, PhD, Professor, Pharmacology & Chemical Biology Adrian Lee, PhD, Professor, Pharmacology & Chemical Biology, Anda Vlad, MD, PhD, Professor, Obstetrics, Gynecology, & Reproductive Sciences Robert Edwards, MD, Chair, Obstetrics and Gynecology, Magee-Womens Hospital of UPMC Dissertation Advisor: Steffi Oesterreich, PhD, Professor, Pharmacology & Chemical Biology ii Copyright © by Courtney L. Andersen 2016 iii TARGETING ESTROGEN RECEPTOR AS A STRATEGY FOR PERSONALIZED MEDICINE IN OVARIAN CANCER Courtney L. Andersen, PhD University of Pittsburgh, 2016 Ovarian cancer comprises a diverse set of diseases that are difficult to detect and treat successfully. Improving outcomes for ovarian cancer patients is contingent upon identifying targeted, individualized therapeutic strategies. One promising but under-utilized target is estrogen receptor-alpha (ER). ER is expressed in ~70% of epithelial ovarian cancers and epidemiologic studies implicate a role for estrogen in ovarian tumorigenesis. Further, clinical data suggest that a subset of ovarian cancer patients benefit from endocrine therapy. We hypothesized that ER drives development and progression of a subset of ovarian tumors and that outputs of ER function would identify patients who respond to endocrine therapy.
    [Show full text]
  • The Doublesex-Related Dmrta2 Safeguards Neural Progenitor
    The doublesex-related Dmrta2 safeguards neural PNAS PLUS progenitor maintenance involving transcriptional regulation of Hes1 Fraser I. Younga, Marc Keruzoreb,1, Xinsheng Nanc,1, Nicole Genneta, Eric J. Bellefroidb,2, and Meng Lia,c,2 aNeuroscience and Mental Health Research Institute, School of Medicine, Cardiff University, Cardiff CF24 4HQ, United Kingdom; bInstitute of Neuroscience, Université Libre de Bruxelles, B-6041 Gosselies, Belgium; and cSchool of Bioscience, Cardiff University, Cardiff CF24 4HQ, United Kingdom Edited by Anders Bjorklund, Lund University, Lund, Sweden, and approved May 16, 2017 (received for review March 29, 2017) The mechanisms that determine whether a neural progenitor cell onic brain, however (9, 10). Dmrta2 loss of function in zebrafish (NPC) reenters the cell cycle or exits and differentiates are pivotal for leads to significant reductions in cortical size, coupled with re- generating cells in the correct numbers and diverse types, and thus duced neuronal numbers (10, 11). Likewise, a smaller neocortex, dictate proper brain development. Combining gain-of-function and particularly the dorsomedial neocortex, has been observed in mice loss-of-function approaches in an embryonic stem cell-derived cortical carrying null deletions of Dmrta2 (12–14). Together with the as- differentiation model, we report that doublesex- and mab-3–related sociation of DMRTA2 mutation and microlissencephaly in humans, transcription factor a2 (Dmrta2, also known as Dmrt5) plays an im- these findings implicate Dmrta2 as an important regulator for cortical portant role in maintaining NPCs in the cell cycle. Temporally controlled neurogenesis. expression of transgenic Dmrta2 in NPCs suppresses differentiation Dmrta2-null mice also exhibit agenesis of the embryonic cor- Dmrta2 without affecting their neurogenic competence.
    [Show full text]
  • Molecular Networks of the FOXP2 Transcription Factor in the Brain
    Review Molecular networks of the FOXP2 transcription factor in the brain Joery den Hoed1,2 , Karthikeyan Devaraju1 & Simon E Fisher1,3,* Abstract investigated contributions of common variation in FOXP2 to geneti- cally complex traits. For example, some studies of small samples The discovery of the FOXP2 transcription factor, and its implica- proposed that single nucleotide polymorphisms (SNPs) in the tion in a rare severe human speech and language disorder, has led FOXP2 gene are associated with schizophrenia risk (Spaniel et al, to two decades of empirical studies focused on uncovering its 2011; Li et al, 2013; Rao et al, 2017), but there is little evidence of roles in the brain using a range of in vitro and in vivo methods. replication (Yin et al, 2018). Large-scale systematic genome-wide Here, we discuss what we have learned about the regulation of association studies have identified significant associations of FOXP2, its downstream effectors, and its modes of action as a intronic FOXP2 SNPs with several traits, including attention-deficit/ transcription factor in brain development and function, providing hyperactivity disorder (ADHD) (Demontis et al, 2019) and risk- an integrated overview of what is currently known about the criti- taking behaviors (Clifton et al, 2018). Although rare disruptions in cal molecular networks. FOXP2 have been associated with changes in brain activity (Liegeois et al, 2003) and structure (Watkins et al, 2002; Liegeois Keywords FOXP2; molecular network; neurodevelopment; speech disorder; et al, 2016; Argyropoulos et al, 2019), common variation could not transcription factor be linked to task-based neural activations on language tasks Subject Categories Chromatin, Transcription & Genomics; Neuroscience (Udden et al, 2019) or neuroanatomical differences between indi- DOI 10.15252/embr.202152803 | Received 5 March 2021 | Revised 19 May viduals (Hoogman et al, 2014).
    [Show full text]